000			01573 a2200457 4500
005			20250513145714.0
264		0	_c19980805
008			199808s 0 0 eng d
022			_a0950-9232
024	7		_a10.1038/sj.onc.1201820 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhang, H T
245	0	0	_aAbsence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential. _h[electronic resource]
260			_bOncogene _cJun 1998
300			_a2835-42 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAmino Acid Substitution
650	0	4	_aAnimals
650	0	4	_aBinding Sites
650	0	4	_aCell Division
650	0	4	_aCell Transformation, Neoplastic
650	0	4	_aEpidermal Growth Factor _xpharmacology
650	0	4	_aErbB Receptors _xmetabolism
650	0	4	_aMitogens _xpharmacology
650	0	4	_aMutagenesis, Site-Directed
650	0	4	_aOncogenes
650	0	4	_aPhenylalanine _xgenetics
650	0	4	_aPhosphorylation
650	0	4	_aRats
650	0	4	_aReceptor, ErbB-2 _xgenetics
650	0	4	_aTyrosine _xgenetics
700	1		_aO'Rourke, D M
700	1		_aZhao, H
700	1		_aMurali, R
700	1		_aMikami, Y
700	1		_aDavis, J G
700	1		_aGreene, M I
700	1		_aQian, X
773	0		_tOncogene _gvol. 16 _gno. 22 _gp. 2835-42
856	4	0	_uhttps://doi.org/10.1038/sj.onc.1201820 _zAvailable from publisher's website
999			_c9637337 _d9637337